文献速递主动脉疾病

整合新型复合炎症指标预测TBAD患者TEVAR术后远端主动脉负性重塑的风险模型

A Risk Prediction Model for Distal Aortic Negative Remodeling after TEVAR in Type B Aortic Dissection was Developed by Incorporating Novel Comprehensive Inflammatory Indices.
PubMed 文献 · Ann Vasc Surg · 2026-01-30

本研究回顾性纳入2015年1月至2022年6月在承德医学院附属医院接受TEVAR的TBAD患者,构建远端主动脉负性重塑风险预测模型。独立预测因子包括单纯性肾囊肿史、SIRI、PNI、远端破口数、假腔不完全血栓形成及假腔通畅,列线图模型C-index为0.85,内部验证0.82,外部验证0.80。

要点

  • 单纯性肾囊肿史、SIRI升高、PNI降低、远端破口数多、假腔不完全血栓及假腔通畅是独立预测因子。
  • 列线图模型区分度良好,C-index 0.85,内部验证0.82,外部验证0.80。
  • 临床决策曲线显示模型在阈值概率2-80%范围内提供良好净临床获益。

核心结论

  • 整合新型复合炎症指标、单纯性肾囊肿、远端破口数、假腔不完全血栓形成及假腔通畅的列线图模型可早期识别TBAD患者TEVAR术后远端主动脉负性重塑高风险人群。

研究设计与样本

  • 回顾性研究纳入2015年1月至2022年6月在承德医学院附属医院接受TEVAR的TBAD患者299例,按70%和30%随机分为训练集209例和内部验证集90例,外部验证队列66例。

主要发现

  • 单纯性肾囊肿史OR=4.80(95%CI 1.32-17.52),SIRI OR=1.39(95%CI 1.09-1.81),PNI OR=0.88(95%CI 0.78-0.98)。
  • 远端破口数OR=3.67(95%CI 1.85-7.69),假腔不完全血栓形成OR=2.93(95%CI 1.05-8.19),假腔通畅OR=4.91(95%CI 1.60-15.32)。
  • 模型C-index为0.85(95%CI 0.78-0.92),内部验证C-index为0.82(95%CI 0.72-0.92),外部验证C-index为0.80(95%CI 0.63-0.97)。
  • 临床决策曲线分析显示模型在阈值概率2-80%(模型)、5%-75%(内部验证)和5-75%(外部验证)范围内提供良好净临床获益。

关键数值与推荐

  • 列线图模型纳入单纯性肾囊肿史、SIRI、PNI、远端破口数、假腔不完全血栓形成及假腔通畅六个预测因子。
  • 模型区分度C-index为0.85(95%CI 0.78-0.92),内部验证0.82(95%CI 0.72-0.92),外部验证0.80(95%CI 0.63-0.97)。
  • 校准曲线显示内部和外部队列中观察结局与预测结局一致性良好。

临床怎么用

  • 对于TBAD患者TEVAR术后,可依据单纯性肾囊肿史、SIRI、PNI、远端破口数、假腔不完全血栓形成及假腔通畅等因素评估远端主动脉负性重塑风险。
  • 列线图模型有助于早期识别高风险患者,支持及时采取预防或干预策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To investigate independent predictors of distal aortic negative remodeling following thoracic endovascular aortic repair (TEVAR) in patients with Stanford type B aortic dissection (TBAD) and to establish a risk prediction model by integrating novel composite inflammatory markers. METHODS: This retrospective study included TBAD patients who underwent TEVAR at the Affiliated Hospital of Chengde Medical University between January 2015 and June 2022. Patients were categorized into negative remodeling and nonnegative remodeling groups based on changes in the true and false lumen diameters of the distal aorta during follow-up; factors influencing distal aortic negative remodeling following TEVAR were analyzed. The final cohort was randomly divided into training (70%) and validation (30%) sets for internal validation. In the training set, univariate analysis was first performed to identify potential predictors, followed by receiver operating characteristic curve analysis for significant continuous variables; variables with statistical significance were further selected using Log-Lambda transformation and least absolute shrinkage and selection operator regression with 10-fold cross-validation. Multivariate logistic regression was then applied to the selected variables to construct the predictive model. Model performance was assessed through discrimination (C-index), calibration curves, and clinical decision curve analysis (DCA). Model rationality was also evaluated by comparing its predictive performance with that of individual clinical indicators. RESULTS: A total of 299 patients were enrolled, with 209 assigned to the training set 90 to the internal validation set; 66 patients comprised the external validation cohort. Independent predictors for distal aortic negative remodeling after TEVAR in TBAD included a history of simple renal cysts (OR = 4.80, 95% CI: 1.32-17.52), systemic inflammation response index (OR = 1.39, 95% CI: 1.09-1.81), prognostic nutritional index (OR = 0.88, 95% CI: 0.78-0.98), number of distal tears (OR = 3.67, 95% CI: 1.85-7.69), incomplete thrombosis of the false lumen (OR = 2.93, 95% CI: 1.05-8.19), and patent false lumen (OR = 4.91, 95% CI: 1.60-15.32). These variables were incorporated into a nomogram model. The model demonstrated strong discriminative ability, with a C-index of 0.85 (95% CI: 0.78-0.92), and the internal validation concordance index was 0.82 (95% CI: 0.72-0.92) and 0.80 (95% CI: 0.63-0.97) for external validation. The nomogram demonstrated good discriminatory ability in both internal and external validation. The calibration curves of the nomogram model demonstrated good agreement between observed and predicted outcomes in both internal and external cohorts. Clinical DCA indicated that the nomogram model provided a favorable net clinical benefit across threshold probabilities of 2-80% (model), 5%-75% (internal validation), and 5-75% (external validation). Rationality analysis revealed superior discrimination and clinical utility compared to conventional clinical parameters. CONCLUSION: The proposed nomogram model, combining novel composite inflammatory markers, simple renal cysts, distal tear count, incomplete thrombosis of the false lumen, and patent false lumen, enables early identification of high-risk patients for distal aortic negative remodeling following TEVAR for TBAD, supporting timely preventive or interventional strategies.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Wang Q, Huo J, Xiao Y, et al. A Risk Prediction Model for Distal Aortic Negative Remodeling after TEVAR in Type B Aortic Dissection was Developed by Incorporating Novel Comprehensive Inflammatory Indices. Ann Vasc Surg. 2026. PMID: 41619933. doi:10.1016/j.avsg.2025.12.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。